Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial

Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren

(2009) Roland E. Schmieder et al.   CIRCULATION

Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome

(2009) Kai M. Eggers et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aliskiren

(2008) Morris J. Brown   CIRCULATION

Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure

(2008) John J.V. McMurray et al.   Circulation-Heart Failure

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET